LifeMD, Inc.: financial statements

LFMDNASDAQHealthcare · Services-Offices & Clinics of Doctors of Medicine

Price

$2.19

November 13, 2026Market cap $105M

What Ploutos Investor adds for LifeMD

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 14 fiscal years, from 2012
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 33% since Nov 12, 2026, when the 10-Q these figures come from was filed ($1.66 then, $2.20 on Nov 13, 2026). The figures date from before that move.10-Q

Financial statements

Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.

2023–2025 fiscal years

Click a line to see it on the chart.

Revenue

+12.8% a year over 2 years

Line202320242025Average a year
Revenue $153M$155M$194M+12.8%
Cost of revenue $19M$21M$28M+21.1%
Gross profit $134M$133M$166M+11.6%
Operating income -$14M-$20M-$7.7M
Net income -$21M-$21M$14M
Earnings per share –-$0.60$0.25
Earnings per share, basic –-$0.60$0.25
Margins
Gross margin 87.6%86.2%85.7%
Operating margin -9.5%-13.2%-4.0%
Net margin -13.5%-13.8%7.4%

Financial statements

LFMD's revenue, profits and cash flows from 2012 to 2022, 11 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

By segment

Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.

  • 2022: Telehealth $83M, Medifast Collaboration Revenue –, Work Simpli $36M
  • 2023: Telehealth $98M, Medifast Collaboration Revenue $5.0M, Work Simpli $54M
  • 2024: Telehealth $155M, Medifast Collaboration Revenue $5.0M, Work Simpli –
Segment202220232024Share 2024
Telehealth$83M$98M$155M97%
Medifast Collaboration Revenue–$5.0M$5.0M3.1%

By segment

LFMD's revenue by segment from 2020 to 2021, 2 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

From the XBRL of 11 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.

Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.

Debt and obligations

What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.

$6.3M Leases-0.5% Effective tax rate

Leases

Dec 31, 2025

Operating leases

$6.3M

Finance leases

–

The liability is the present value of the rent still to pay, at December 31, 2025. It is not counted in the ladder's debt. The filing

From the statutory to the effective tax rate, 2025

Dec 31, 2025

Effective rate

-0.5%

The lines the company states do not reach its effective rate, so we do not show them. Both rates are the filing's. The filing

Earnings quality

How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.

Receivables and inventory against sales

In the quarter to Sep 30, 2026, sales were -6.5% on the same quarter a year earlier, and receivables +43.3%. Inventory was +201.5%, against +16.8% for the cost of sales.

  • Days of sales in receivables rose more than at nine in ten S&P 500 companies.
  • Days of cost in inventory rose more than at nine in ten S&P 500 companies.
a year earlier 18 days
27 days
a year earlier 44 days
114 days

Balances at Sep 30, 2026 and Sep 30, 2025, against the sales and cost of sales of the quarter ending on each date; a fourth quarter is the fiscal year less its first nine months. Same quarter against same quarter, so the season is the same.

Allowance for doubtful accounts

The allowance for receivables that may not be collected was 1.5% of gross receivables at Sep 30, 2026, against 7.4% a year earlier.

At last year's share it would be $800.2K larger. A smaller allowance means a smaller charge for bad debts in profit.

  • The share fell more than at nine in ten S&P 500 companies that report it.
a year earlier $739.0K
$195.0K

The earnings per share split is not shown: it needs a profit before tax in both years, since a tax rate on a loss has no meaning as a source.

The tax part is not shown: a figure it needs is missing from the company's structured filings.

A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.

The full analysis

What do LifeMD's filings show?

These are LifeMD's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about LFMD's financials

Didn't find what you were looking for?

Ask us
How much revenue did LFMD have in 2025?

LifeMD had revenue of $194M and net income of $14M in fiscal 2025, a net margin of 7.4%.

How much debt does LFMD have?

On December 31, 2025 LifeMD had total assets of $70M, debt of – and shareholders' equity of $23M.

How much free cash flow does LFMD have?

In fiscal 2025 LifeMD had cash from operations of $8.3M and spent $1.9M on capital expenditure, leaving $6.4M of free cash flow.

Where are the figures from?

From LifeMD, Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.